Section: Partnerships and Cooperations
Participants : David James Sherman [correspondant] , Natalia Golenetskaya.
A major objective of the “post-genome” era is to detect, quantify and characterise all relevant human proteins in tissues and fluids in health and disease. This effort requires a comprehensive, characterised and standardised collection of specific ligand binding reagents, including antibodies, the most widely used such reagents, as well as novel protein scaffolds and nucleic acid aptamers. Currently there is no pan-European platform to coordinate systematic development, resource management and quality control for these important reagents.
Magnome is an associate partner of the FP7 “Affinity Proteome ” project coordinated by Prof. Mike Taussig of the Babraham Institute and Cambridge University. Within the consortium, we participate in defining community for data representation and exchange, and evaluate knowledge engineering tools for affinity proteomics data.